|
|
|
| |
Tayside Flow Technologies Ltd (TFT) is a medical technology company focussed on the development of vascular devices based on a new understanding of blood flow dynamics, Spiral Laminar Flow™.
Spiral Laminar Flow (SLF™) is a proprietary platform technology developed by TFT.
TFT aims to develop innovative products to address unmet clinical needs in this £11 billion ($18billion) market with annual growth rates of 10%.
The process of blockage at graft-vessel join and within vascular stents is driven to a large part by disturbed flow. TFT grafts and stents delivering less turbulent energy by utilizing spiral laminar flow™ will;
|
- improve device patency
- prolong the effective life of devices
- reduce downstream disease progression
- improve patient quality of life
|
TFT is a private company and is led by a strong management team with specific sector and high growth businesses experience.
|
|
|
© John McGhee & Dr. Graeme Houston - Computer simulation of blood cell flow
|
| |
|
